Sartorius Stedim Biotech S.A. (EPA: DIM)

Market Cap	17.91B
Revenue (ttm)	2.75B
Net Income (ttm)	169.50M
Shares Out	97.31M
EPS (ttm)	1.80
PE Ratio	102.32
Forward PE	44.83
Dividend	0.69 (0.38%)
Ex-Dividend Date	Apr 2, 2024

Volume	58,269
Open	182.80
Previous Close	183.70
Day's Range	182.80 - 185.90
52-Week Range	139.10 - 281.00
Beta	0.66
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 17, 2024

About Sartorius Stedim Biotech

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management servic...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1978
• Employees: 10,382
• Stock Exchange: Euronext Paris
• Ticker Symbol: DIM

Financial Performance

In 2023, VIE's revenue was 45.35 billion, an increase of 5.75% compared to the previous year's 42.89 billion. Earnings were 937.00 million, an increase of 30.87%.